These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 29777655

  • 21. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S, Hussain N, Hurdman J, Billings C, Charalampopoulos A, Elliot CA, Kiely DG, Sabroe I, Rajaram S, Swift AJ, Condliffe R.
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [Abstract] [Full Text] [Related]

  • 22. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [Abstract] [Full Text] [Related]

  • 23. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC, Hummers LK, Champion HC, Wigley FM, Zaiman A, Hassoun PM, Girgis RE.
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.
    Pasarikovski CR, Granton JT, Roos AM, Sadeghi S, Kron AT, Thenganatt J, Moric J, Chau C, Johnson SR.
    Arthritis Res Ther; 2016 Jan 27; 18():30. PubMed ID: 26819137
    [Abstract] [Full Text] [Related]

  • 26. Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohort.
    Santosa A, Tan CS, Teng GG, Fong W, Lim A, Law WG, Chan G, Ng SC, Low A.
    Scand J Rheumatol; 2016 Nov 27; 45(6):499-506. PubMed ID: 27232525
    [Abstract] [Full Text] [Related]

  • 27. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.
    Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG.
    Arthritis Rheum; 2013 Apr 27; 65(4):1074-84. PubMed ID: 23280155
    [Abstract] [Full Text] [Related]

  • 28. Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension.
    Morrisroe K, Stevens W, Huq M, Prior D, Sahhar J, Ngian GS, Celermajer D, Zochling J, Proudman S, Nikpour M, Australian Scleroderma Interest Group (ASIG).
    Arthritis Res Ther; 2017 Jun 02; 19(1):122. PubMed ID: 28576149
    [Abstract] [Full Text] [Related]

  • 29. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E.
    Chest; 2011 Oct 02; 140(4):1016-1024. PubMed ID: 21474572
    [Abstract] [Full Text] [Related]

  • 30. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA.
    Ann Rheum Dis; 2010 Oct 02; 69(10):1809-15. PubMed ID: 20551155
    [Abstract] [Full Text] [Related]

  • 31. Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.
    Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD.
    J Rheumatol; 2019 Feb 02; 46(2):176-183. PubMed ID: 30275260
    [Abstract] [Full Text] [Related]

  • 32. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H, Steen V, Allanore Y, Saggar R, Saggar R, Maranian P, Berrocal VJ, Avouac J, Meune C, Trivedi M, Khanna D.
    J Rheumatol; 2013 Oct 02; 40(10):1706-11. PubMed ID: 23950183
    [Abstract] [Full Text] [Related]

  • 33. Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension.
    Johnson SR, Swiston JR, Granton JT.
    J Rheumatol; 2008 Aug 02; 35(8):1584-90. PubMed ID: 18597400
    [Abstract] [Full Text] [Related]

  • 34. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, Zaiman A, Sitbon O, Simonneau G, Humbert M, Hassoun PM.
    Arthritis Rheum; 2011 Aug 02; 63(8):2456-64. PubMed ID: 21538327
    [Abstract] [Full Text] [Related]

  • 35. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.
    Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J, Launay D, Mouthon L, Jego P, Cabane J, de Groote P, Chabrol A, Lazareth I, Guillevin L, Clerson P, Humbert M, ItinérAIR-Sclérodermie Study Investigators.
    Rheumatology (Oxford); 2009 Mar 02; 48(3):304-8. PubMed ID: 19174571
    [Abstract] [Full Text] [Related]

  • 36. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.
    Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG.
    Am J Respir Crit Care Med; 2009 Jan 15; 179(2):151-7. PubMed ID: 18931333
    [Abstract] [Full Text] [Related]

  • 37. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O, Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis.
    J Rheumatol; 2011 Nov 15; 38(11):2419-27. PubMed ID: 21965635
    [Abstract] [Full Text] [Related]

  • 38. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD.
    Circulation; 2010 Jul 13; 122(2):164-72. PubMed ID: 20585012
    [Abstract] [Full Text] [Related]

  • 39. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT.
    Clin Exp Rheumatol; 2017 Jul 13; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [Abstract] [Full Text] [Related]

  • 40. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ, Khair RM, Damico RL, Kolb TM, Hummers LK, Hassoun PM, Steen VD, Mathai SC, PHAROS Investigators.
    Arthritis Rheumatol; 2019 Oct 13; 71(10):1691-1700. PubMed ID: 31066998
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.